Yahoo
Taipei Exchange - Delayed Quote TWD

Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO)

7.00 -0.02 (-0.28%)
At close: 2:56:09 PM GMT+8
Chart Range Bar
Loading chart for 4186.TWO
  • Previous Close 7.02
  • Open 7.02
  • Bid 6.87 x --
  • Ask 7.00 x --
  • Day's Range 6.87 - 7.02
  • 52 Week Range 6.68 - 13.75
  • Volume 17,065
  • Avg. Volume 102,463
  • Market Cap (intraday) 630M
  • Beta (5Y Monthly) 0.32
  • PE Ratio (TTM) 41.18
  • EPS (TTM) 0.17
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Taiwan Advance Bio-Pharmaceutical Inc. operates in the biotechnology industry in China, Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally. The company provides food safety diagnostic testing kits; ELISA and rapid test kits customization, and food safety lab establishment consultation services; and manufactures monoclonal and polyclonal antibody products. It also offers stem cell banking services for newborn and adult stem cells storage; cell therapy programs; abused drugs rapid tests; operates drug testing center for urine drug test, hair drug test, and identification of drug abuse. The company also involves in research, development, production, and sales of veterinary drug residue testing reagents, drug abuse certification testing services and management, detection, extraction, cryopreservation and storage, and gene testing services for umbilical cord blood stem cells, umbilical cord mesenchymal stem cells, peripheral blood stem cells, and related businesses. Taiwan Advance Bio-Pharmaceutical Inc. was founded in 1989 and is based in Taipei, Taiwan.

www.biotest.com.tw

160

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

4186.TWO
37.22%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
55.09%

1-Year Return

4186.TWO
46.97%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
59.10%

3-Year Return

4186.TWO
59.65%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
173.95%

5-Year Return

4186.TWO
66.02%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
163.21%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.52%

  • Return on Assets (ttm)

    2.32%

  • Return on Equity (ttm)

    6.05%

  • Revenue (ttm)

    348.54M

  • Net Income Avi to Common (ttm)

    15.76M

  • Diluted EPS (ttm)

    0.17

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    157.98M

  • Total Debt/Equity (mrq)

    109.60%

  • Levered Free Cash Flow (ttm)

    4.37M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: